Clinical Decision Support System for Quality Assurance in Potassium-Increasing Drug-Drug-Interactions
NCT ID: NCT02020317
Last Updated: 2015-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
3341 participants
INTERVENTIONAL
2014-01-31
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Increasing Potassium Intake in Hypertensive Individuals
NCT02759367
Potassium Supplementation in CKD
NCT03253172
The Effects of Sodium and Potassium on Blood Pressure, Vascular Function and Renal Function
NCT01575041
Blood Pressure Regulation - Role of Potassium
NCT02380157
Tracking Treatment Pathways in Adult Patients With Hyperkalemia.
NCT05408039
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study investigates the impact of reminders for serum potassium monitoring and hyperkalemia alerts. Both reminders and alerts are displayed in the electronic patient chart of in-patients treated with potassium-increasing DDIs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
computer-based reminders and alerts
Behavioral: display of computer-based reminders for serum potassium monitoring and hyperkalemia alerts (decision support in potassium-inc. drug-drug-interactions)
decision support in potassium-inc. drug-drug-interactions
display of computer-based reminders for serum potassium monitoring and hyperkalemia alerts
no computer-based reminders or alerts
Behavioral: no display of computer-based reminders for serum potassium monitoring and hyperkalemia alerts
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
decision support in potassium-inc. drug-drug-interactions
display of computer-based reminders for serum potassium monitoring and hyperkalemia alerts
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juerg Blaser, PhD, Prof
Role: PRINCIPAL_INVESTIGATOR
University Hospital Zurich, Center for Clinical Research, Research Center for Medical Informatics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich, Center for Clinical Research, Research Center for Medical Informatics
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Eschmann E, Beeler PE, Kaplan V, Schneemann M, Zund G, Blaser J. Patient- and physician-related risk factors for hyperkalaemia in potassium-increasing drug-drug interactions. Eur J Clin Pharmacol. 2014 Feb;70(2):215-23. doi: 10.1007/s00228-013-1597-2. Epub 2013 Oct 23.
Eschmann E, Beeler PE, Zund G, Blaser J. Evaluation of alerts for potassium-increasing drug-drug-interactions. Stud Health Technol Inform. 2013;192:1056.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FZMI-KEK-ZH-Nr. 2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.